Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J McNamee

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
JAMA|August 31, 2021
Effect of Lower Tidal Volume Ventilation Facilitated by Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory Failure: The REST Randomized Clinical TrialJames J McNamee, Michael A Gillies, Nicholas A Barrett, et al.
Critical Care Explorations|January 12, 2024
The Effect of Lower Tidal Volume Ventilation Facilitated by Extracorporeal Carbon Dioxide Removal Compared With Conventional Lung Protective Ventilation on Cardiac FunctionPeter J McGuigan, Emma M Bowcock, Nicholas A Barrett, et al.
American Journal of Respiratory and Critical Care Medicine|November 15, 2019
Mechanical Ventilation for Acute Respiratory Distress Syndrome during Extracorporeal Life Support. Research and PracticeDarryl Abrams, Matthieu Schmidt, Tài Pham, et al.
Journal of the Intensive Care Society|October 6, 2017
pRotective vEntilation with veno-venouS lung assisT in respiratory failure: A protocol for a multicentre randomised controlled trial of extracorporeal carbon dioxide removal in patients with acute hypoxaemic respiratory failureJ J McNamee, M A Gillies, N A Barrett, et al.
Pediatrics|December 4, 2023
Pediatric Sport-Related Concussion: Recommendations From the Amsterdam Consensus Statement 2023Gavin A Davis, Kathryn J Schneider, Vicki Anderson, et al.
Nature Medicine|October 10, 2023
Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trialJamie E Chaft, Filiz Oezkan, Mark G Kris, et al.
Nature Medicine|September 13, 2022
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trialJamie E Chaft, Filiz Oezkan, Mark G Kris, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 11, 2022
Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non-small cell lung cancerValerie W Rusch, Alan Nicholas, G Alexander Patterson, et al.
British Journal of Sports Medicine|March 4, 2026
Harmful anachronism: World Athletics reinstates gene testing to participate in women's competitionsSilvia Camporesi, Shane M Heffernan, Pascal Borry, et al.
Current Sports Medicine Reports|December 14, 2019
The Olympia DeclarationYannis P Pitsiladis, Manolis Abatzis-Papadopoulos, Nemer Ali, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
JAMA|August 31, 2021
Effect of Lower Tidal Volume Ventilation Facilitated by Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory Failure: The REST Randomized Clinical TrialJames J McNamee, Michael A Gillies, Nicholas A Barrett, et al.
Critical Care Explorations|January 12, 2024
The Effect of Lower Tidal Volume Ventilation Facilitated by Extracorporeal Carbon Dioxide Removal Compared With Conventional Lung Protective Ventilation on Cardiac FunctionPeter J McGuigan, Emma M Bowcock, Nicholas A Barrett, et al.
American Journal of Respiratory and Critical Care Medicine|November 15, 2019
Mechanical Ventilation for Acute Respiratory Distress Syndrome during Extracorporeal Life Support. Research and PracticeDarryl Abrams, Matthieu Schmidt, Tài Pham, et al.
Journal of the Intensive Care Society|October 6, 2017
pRotective vEntilation with veno-venouS lung assisT in respiratory failure: A protocol for a multicentre randomised controlled trial of extracorporeal carbon dioxide removal in patients with acute hypoxaemic respiratory failureJ J McNamee, M A Gillies, N A Barrett, et al.
Pediatrics|December 4, 2023
Pediatric Sport-Related Concussion: Recommendations From the Amsterdam Consensus Statement 2023Gavin A Davis, Kathryn J Schneider, Vicki Anderson, et al.
Nature Medicine|October 10, 2023
Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trialJamie E Chaft, Filiz Oezkan, Mark G Kris, et al.
Nature Medicine|September 13, 2022
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trialJamie E Chaft, Filiz Oezkan, Mark G Kris, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 11, 2022
Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non-small cell lung cancerValerie W Rusch, Alan Nicholas, G Alexander Patterson, et al.
British Journal of Sports Medicine|March 4, 2026
Harmful anachronism: World Athletics reinstates gene testing to participate in women's competitionsSilvia Camporesi, Shane M Heffernan, Pascal Borry, et al.
Current Sports Medicine Reports|December 14, 2019
The Olympia DeclarationYannis P Pitsiladis, Manolis Abatzis-Papadopoulos, Nemer Ali, et al.
Pageof 11